Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Muscle-Invasive Bladder Cancer: A Watershed Moment
Matthew D. Galsky
, Leslie Ballas
, Ashish M. Kamat
Cancer Clinical Investigation
Graduate School of Biomedical Sciences
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - Hematology and Medical Oncology
Mount Sinai Tisch Cancer Center
Urology
Research output
:
Contribution to journal
›
Review article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Muscle-Invasive Bladder Cancer: A Watershed Moment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Muscle-invasive Bladder Cancer
100%
Immune Checkpoint Blockade
50%
Clinical Trials
33%
Treatment Efficacy
33%
Risk-adapted
33%
Neoadjuvant Setting
33%
Improved Outcomes
16%
Comorbidity
16%
Treatment Strategy
16%
Pathological Complete Response
16%
Systemic Therapy
16%
Age-related Changes
16%
Standard of Care
16%
Physiological Function
16%
Older Individuals
16%
Concurrent Chemotherapy
16%
Minimal Residual Disease
16%
Perioperative Setting
16%
Complete Response Rate
16%
Clinical Utility
16%
Radical Cystectomy
16%
Cancer Care
16%
Circulating Tumor DNA (ctDNA)
16%
Therapy Regimen
16%
Antibody-drug Conjugate
16%
Bladder-sparing
16%
Preoperative Systemic Therapy
16%
Medicine and Dentistry
Muscle Invasive Bladder Cancer
100%
Immune Checkpoint Blockade
60%
Clinical Trial
40%
Systemic Therapy
40%
Biological Marker
20%
Bladder
20%
Cystectomy
20%
Minimal Residual Disease
20%
Circulating Tumor DNA
20%
Antibody-Drug Conjugate
20%
Muscle Invasive Treatment of Bladder Cancer
20%
Comorbidity
20%
Diseases
20%